Basics Arcellx, Inc. Common Stock IPO Date: February 4, 2022 Sector: Healthcare Industry: Biotech Market Cap: $4.16B Activated in VL: True Average Daily Range Avg Daily Range: $1.19 | 2.71% Avg Daily Range (30 D): $2.17 | 2.63% Avg Daily Range (90 D): $1.66 | 2.08% Institutional Daily Volume Avg Daily Volume: .43M Avg Daily Volume (30 D): .95M Avg Daily Volume (90 D): .61M Trade Size Avg Trade Size (Sh.): 53 Avg Trade Size (Sh.) (30 D): 62 Avg Trade Size (Sh.) (90 D): 54 Institutional Trades Total Inst.Trades: 2,265 Avg Inst. Trade: $2.71M Avg Inst. Trade (30 D): $2.95M Avg Inst. Trade (90 D): $3.51M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.24M Avg Closing Trade (30 D): $6.47M Avg Closing Trade (90 D): $5.61M Avg Closing Volume: 79.86K     News Oct 8, 2025 @ 5:00 PM CAR T-Cell Therapy for Multiple Myeloma Market to ... Source: Delveinsight May 23, 2025 @ 1:10 PM New Data and Deal Flow Signal a Turning Point for ... Source: Prnewswire May 12, 2025 @ 5:00 PM Blood Cancer Treatment Market Sees Accelerated Gro... Source: Delveinsight Mar 5, 2025 @ 6:00 PM CAR T-cell Therapy Clinical Trial Pipeline Experie... Source: Delveinsight Feb 12, 2025 @ 8:22 PM Gilead Ups 2025 Outlook, Eyes Lenacapavir Launch F... Source: Vandana Singh Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.99 $-.94 Diluted EPS $-.99 $-.94 Revenue $ $ 4.95M $ 7.55M Gross Profit $ $ $ Net Income / Loss $ $ -55.78M $ -52.77M Operating Income / Loss $ $ -61.78M $ -58.73M Cost of Revenue $ $ $ Net Cash Flow $ $ 16.87M $ -18.73M PE Ratio